Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
What Are The Biggest Risks For Kennedy Wilson Holdings Kw Stock Price At 10.88 Up 0.14 20260410 What Is The Future Of Verrica Pharmaceuticals Vrca Stock Price At 5.40 Down 7.38 20260410 What Caused Leishen Lse Stock To Drop Recently Price At 5.22 Down 4.40 20260409 Should I Buy Blaize Bzai Stock In 2026 Price At 1.95 Up 8.66 20260406 Is Xai Xflt Stock Trending Down Price At 16.80 Up 0.33 20260406 FG FGN Stock Block Trades Weakens 20260415 aTyr Pharma ATYR Stock Commodity Trade Investors Pile In 20260418 The long term thesis for Acadia ACAD in plain sight Technical Weakness 20260510 Peoples PEBK Stock Key Support Breakout Watch 20260418 Grace Therapeutics GRCE Stock vs Competition Volatility Increases 20260422 The shareholder friendly policies at Hyliion Holdings HYLN HYLN Q3 Earnings Hyliion Holdings Reports No Updates as Costs Mount SAZ Saratoga posts 227 percent Q1 2026 earnings beat registers slight share price gain in todays trading XOMAP XOMA delivers massive Q4 2025 earnings beat sending its shares modestly higher in daily trading Is it too late to buy Grand LOPE stock Q4 2025 Earnings Underperform CMC Commercial reports Q1 2026 EPS below consensus estimates shares rise 345 as investors take a long term view Is Vishay VPG building a durable competitive moat Flirts with Support 20260506 How BTC Warrant BDCIW is investing for future growth BDCIW Q3 Earnings BTC Warrant Reports No Earnings Data Why FirstSun FSUN is a smarter play than most realize Grinds Higher 20260506 STLA Stellantis reports steep Q4 2025 EPS miss shares slide 204 percent as investor sentiment sours Elastic NV ESTC Q1 2026 Earnings Why the Beat Matters Xi Jinping Reassures US Firms China to Open Door Wider Amid Trump Visit Priority PRTH Crushes Q1 2026 Estimates EPS 028 Tops Views Funds Coin Expands MultiAgent AI Trading Infrastructure Across Gold Forex and Equity Markets Relay Therapeutics RLAY Drops 196 Key Support at 1190 20260515 Wolfspeed WOLF Down 533 How Low Could It Go 20260518 OECD Consumer Prices Update Signals Evolving Inflation Landscape Duke Energy DUK Stock Down 162 Support Test at 11519 20260515 Molson Coors TAP Edges Lower Stock Holds Near Key Support Levels Amid Modest Pullback enGene Holdings Warrants ENGNW Edge Higher in Tight Range Inspira IINN Q4 2023 Earnings Surprise EPS 017 Up Significant Trump Administration Drops Civil and Criminal Cases Against Adani Group Following 10 Billion Investment Pledge UKGulf Trade Deal Poised as Monumental Achievement Says Bahrain Minister in CNBC Interview Spotify CEO Defends AI Music Remix Tool as Better Alternative to Piracy Swiss Franc and Japanese Yen Strengthen as DeepSeek AI News Sparks SafeHaven Demand Indias Gen Z Cockroach Movement Gains Momentum Amid Exam Controversy Website Taken Down Rail Vikas Nigam Suzlon ONGC Among Key Companies Set to Declare Q4 Results Next Week SCSC Q1 2026 Earnings Marginal EPS Miss Amidst Operational Stability Plexus Corp Q1 2026 Earnings EPS Beats Estimates by 678 Revenue Data Withheld TransMedics Group TMDX Q1 2026 Earnings EPS Misses Estimates by Wide Margin Stock Edges Lower HESM Q1 2026 Earnings EPS Beat of 325 Drives Modest Stock Gain CSW Industrials Q1 2026 Earnings EPS Miss Masks Operational Resilience as Shares Rally Embecta Corp EMBC Holds Steady at 332 as Traders Await Clear Direction EVgo Inc EVGO Rises 186 Testing Key Resistance at 202 OKYO Pharma Shares Edge Higher as Biotech Momentum Builds Glacier Bancorp GBCI Jumps Nearly 2 as Shares Approach Key Resistance Level How FTAI FTAIM insider activity aligns with performance FTAI posts 152 negative EPS surprise falling short of estimates EL Estee delivers modest Q1 2026 earnings beat shares rise nearly two percent on positive investor sentiment NCI NeoConcept CEO outlines global market expansion priorities following the release of its latest quarterly earnings GIS General Mills falls 167 after Q1 2026 EPS misses consensus analyst estimates by 127 ANIP ANI Pharma smashes Q4 estimates with 438 revenue surge but shares dip despite beat